Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -131.76% is 70% above its 5-year average of -434.15%, near the high end of its 5-year range (-3657.40%–42.41%).
72.12% above its 12-month average of -472.65%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1035.27%.
NET PROFIT MARGIN
-131.76%
NET PROFIT MARGIN AVG TTM
-472.65%
NET PROFIT MARGIN AVG 3Y
-360.04%
NET PROFIT MARGIN AVG 5Y
-434.15%
NET PROFIT MARGIN AVG 10Y
-507.85%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+72.12%
CURRENT VS 3Y AVG
+63.40%
CURRENT VS 5Y AVG
+69.65%
CURRENT VS 10Y AVG
+74.06%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.02%
median of 823 covered companies
CURRENT VS SECTOR MEDIAN
-658700.00%
vs the sector median at left
Jaguar Health, Inc.
Market Cap
$2.49M
Net Profit Margin
-131.76%
TTM Avg
-472.65%
3Y Avg
-360.04%
5Y Avg
-434.15%
Market Cap
$2.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.55M
Net Profit Margin
-257.33%
TTM Avg
-169.26%
3Y Avg
-42605.81%
5Y Avg
-28403.87%
Market Cap
$2.41M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Net Profit Margin
-1578.79%
TTM Avg
-2023.10%
3Y Avg
-17008.17%
5Y Avg
-11338.78%
Market Cap
$2.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.62M
Net Profit Margin
-123.38%
TTM Avg
-169.81%
3Y Avg
-184.41%
5Y Avg
-199.55%
Market Cap
$2.31M
Net Profit Margin
-201355.37%
TTM Avg
-74928.77%
3Y Avg
-55011.63%
5Y Avg
-36705.99%
Market Cap
$2.73M
Net Profit Margin
-2449.04%
TTM Avg
-339.09%
3Y Avg
-222.12%
5Y Avg
-170.97%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.49M | -131.76% | -472.65% | -360.04% | -434.15% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | -257.33% | -169.26% | -42605.81% | -28403.87% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.41M | 0.00% | 0.00% | 0.00% | 0.00% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -1578.79% | -2023.10% | -17008.17% | -11338.78% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | -123.38% | -169.81% | -184.41% | -199.55% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.31M | -201355.37% | -74928.77% | -55011.63% | -36705.99% |
| iSpecimen Inc. (ISPC)vs › | $2.73M | -2449.04% | -339.09% | -222.12% | -170.97% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.07M | -862.34% | -747.16% | -4673.17% | -3945.34% |
Operating Margin
-391.9%
Net Profit Margin
-131.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1035.27% |
| 2026-03-31 | 42.41% |
| 2025-12-31 | -712.86% |
| 2025-09-30 | -308.21% |
| 2025-06-30 | -349.35% |
| 2025-03-31 | -472.63% |
| 2024-12-31 | -282.70% |
| 2024-09-30 | -317.05% |
| 2024-06-30 | -348.84% |
| 2024-03-31 | -392.43% |
| 2023-12-31 | -398.70% |
| 2023-09-30 | -276.50% |
| 2023-06-30 | -454.04% |
| 2023-03-31 | -618.76% |
| 2022-12-31 | -232.55% |
| 2022-09-30 | -397.46% |
| 2022-06-30 | -320.68% |
| 2022-03-31 | -685.18% |
| 2021-12-31 | -688.13% |
| 2021-09-30 | -1935.24% |
| 2021-06-30 | -3657.40% |
| 2021-03-31 | -967.69% |
| 2020-12-31 | -340.41% |
| 2020-09-30 | -283.66% |
| 2020-06-30 | -291.70% |
| 2020-03-31 | -913.23% |
| 2019-12-31 | -395.43% |
| 2019-09-30 | -776.65% |
| 2019-06-30 | -980.31% |
| 2019-03-31 | -522.34% |
| 2018-12-31 | -792.91% |
| 2018-09-30 | -542.23% |
| 2018-06-30 | -866.35% |
| 2018-03-31 | -708.22% |
| 2017-12-31 | -1310.44% |
| 2017-09-30 | 432.63% |
| 2017-06-30 | -201.41% |
| 2017-03-31 | -573.36% |
| 2016-12-31 | -12731.97% |
| 2016-09-30 | -6782.55% |
| 2016-06-30 | -15149.22% |
| 2016-03-31 | -10444.62% |
| 2015-12-31 | -7485.27% |
| 2015-09-30 | -3812.06% |
| 2015-06-30 | -8334.67% |
| 2015-03-31 | -6311.22% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
